West Pharmaceutical Services (WST) : Copper Rock Capital Partners reduced its stake in West Pharmaceutical Services by 0.41% during the most recent quarter end. The investment management company now holds a total of 338,525 shares of West Pharmaceutical Services which is valued at $23.2 Million after selling 1,390 shares in West Pharmaceutical Services according to a report filed by the company on Apr 5, 2016 with the SEC.West Pharmaceutical Services makes up approximately 2.04% of Copper Rock Capital Partners’s portfolio.
Other Hedge Funds, Including ,
On the company’s financial health, West Pharmaceutical Services reported $0.47 EPS for the quarter, based on the information available during the earnings call on Feb 18, 2016. Analyst had a consensus estimate of $0.47. The company had revenue of $359.70 million for the quarter, compared to analysts expectations of $364.76 million. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.
Investors should note that on Mar 4, 2016, West Pharmaceutical Services announced a cash dividend of $0.1200. The company’s management has announced Apr 18, 2016 as the ex-dividend date and fixed the record date on Apr 20, 2016. The payable date has been fixed on May 4, 2016.
Many Wall Street Analysts have commented on West Pharmaceutical Services. West Pharmaceutical Services was Initiated by Wells Fargo to “Outperform” on Mar 22, 2016.
West Pharmaceutical Services closed down -0.63 points or -0.91% at $68.67 with 3,11,046 shares getting traded on Monday. Post opening the session at $69.44, the shares hit an intraday low of $68.42 and an intraday high of $69.83 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).